Davion Healthcare Plc Ordinary Shares (DAVI)

Publicly reported company facts and saved market data for Davion Healthcare Plc Ordinary Shares (DAVI), with sources and as-of times. Saved data is not a live quote.

Company profile

Davion Healthcare Plc is a next-generation digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion's broader portfolio includes technologies addressing circulation and foot health, testicular health, skin anomalies, wound monitoring, blood pressure and other areas of preventive healthcare. Davion's growth strategy combines the development and commercialisation of its proprietary technologies with complementary acquisitions intended to expand the Group's product portfolio and commercial, manufacturing and distribution capabilities.

Company facts

Sector: Health Care
Industry: Surgical & Medical Instruments & Apparatus
Market cap: $67.2M · as of 2026-10-29
Incorporated in: Cyprus
Exchange: NASDAQ

FennEdge notes

Sessions where DAVI appeared in the Small-Cap Daily, newest first: opening gap, day change and the SEC filing or halt stored by the close. Facts with source links.

2026-10-28 #6 top gapper · gap +24.00% · closed +9.67% No SEC filing or news found by the close

All Small-Cap Daily editions

Saved quote

Saved snapshot, not a real-time quote. Check the market time before relying on it.

Last reported price: $1.7288
Reported change: -35.73%
Reported volume: 1,401,786
Latest market time: 2026-10-30 19:59 ET

Float and shares outstanding

DAVI float references and SEC-reported shares outstanding
Measure	Shares	As of	Source and basis
Float	13,477,500	2026-03-31	Reported by a single source; not cross-checked.
Shares outstanding (O/S)	25,225,000	2026-03-28	SEC 20-F/A filing · filed 2026-05-06 Historical: the latest SEC-reported figure is more than six months old.

Dates are measurement dates, not the time FennEdge retrieved the data. Float references are listed separately; they are not averaged or adjusted for later splits or share issuances.

Recent daily sessions

The 5 most recent saved daily sessions, through 2026-10-28. Daily OHLC and volume; not real-time.

DAVI daily open, high, low, close and volume
Date	Open	High	Low	Close	Volume
2026-10-28	3.72	3.81	2.95	3.29	8,533,316
2026-10-27	3.72	3.99	2.78	3.00	6,069,898
2026-10-26	4.86	4.91	3.91	4.07	380,799
2026-10-23	8.89	8.89	5.67	6.00	479,470
2026-10-22	12.25	12.30	9.52	11.65	558,417

Dilution timeline

As of 2026-10-29T23:52:29.801970+00:00

2026-10-20 · 424B3 · Prospectus filed
2026-10-13 · 424B3 · Prospectus filed
2026-09-02 · POS AM · Post-effective amendment filed
2026-08-17 · POS AM · Post-effective amendment filed
2026-05-01 · POS AM · Post-effective amendment filed
2026-04-06 · POS AM · Post-effective amendment filed
2026-03-04 · POS AM · Post-effective amendment filed
2026-02-04 · POS AM · Post-effective amendment filed
2025-12-09 · POS AM · Post-effective amendment filed
2025-12-05 · F-1/A · Registration statement filed
2025-11-07 · F-1/A · Registration statement filed
2025-09-26 · F-1/A · Registration statement filed
2025-08-04 · F-1 · Registration statement filed

Parsed share counts, prices and warrant terms require Plus or above. Explore plans

Research this company

FennEdge organizes SEC filings and reported market data. Sign in for additional research and your private trading context.